Elizabeth Williams

Direttore Finanziario/CFO presso SATELLOS BIOSCIENCE INC.

Patrimonio netto: 34 620 $ in data 30/04/2024

Health Technology

Commercial Services

Consumer Services

Posizioni attive di Elizabeth Williams

Società	Posizione	Inizio	Fine
SATELLOS BIOSCIENCE INC.	Direttore Finanziario/CFO	01/09/2023	-
SATELLOS BIOSCIENCE INC.	Contatto Relazioni con gli Investitori	01/09/2023	-
Triumvira Immunologics USA, Inc. Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018.	Direttore/Membro del Consiglio	-	-

Società	Posizione	Inizio	Fine
MEDICENNA THERAPEUTICS CORP.	Direttore Finanziario/CFO	01/12/2016	14/08/2023
	Contatto Relazioni con gli Investitori	01/12/2016	14/08/2023
	Segretario Aziendale	01/12/2016	14/08/2023
APTOSE BIOSCIENCES INC.	Direttore Amministrativo	01/06/2001	01/12/2016
Ernst & Young LLP (Canada) Ernst & Young LLP (Canada) Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP (Canada) engages in the provision of consulting, assurance, tax, and transaction services. The company is headquartered in Toronto, Canada.	Comptroller/Controller/Auditor	01/08/1998	01/06/2004

Wilfrid Laurier University

Undergraduate Degree

Distribuzione geografica

Canada	6
Stati Uniti	2

Posizioni

Director of Finance/CFO	2
Investor Relations Contact	2
Comptroller/Controller/Auditor	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	3
APTOSE BIOSCIENCES INC.	Health Technology
MEDICENNA THERAPEUTICS CORP.	Health Technology
SATELLOS BIOSCIENCE INC.	Health Technology

Aziende private	2
Ernst & Young LLP (Canada) Ernst & Young LLP (Canada) Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP (Canada) engages in the provision of consulting, assurance, tax, and transaction services. The company is headquartered in Toronto, Canada.	Commercial Services
Triumvira Immunologics USA, Inc. Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018.	Commercial Services